Track topics on Twitter Track topics that are important to you
Pain management start-up Neumentum Inc. (non-opioid analgesic and neurology specialty pharma) raised $6mm in a Series A round in which Brookline Capital Markets was the placement agent.
-- Led by proven executive team, Neumentum is dedicated to becoming a leading non-opioid analgesic and neurology specialty pharmaceutical company -- -- Type B meet...
-- May 8 Type B meeting confirmed to discuss the clinical development program for lead product candidate NTM-001, which has potential to treat moderately severe acute postoperativ...
Neumentum is developing and plans to commercialize products that have the potential to effectively treat pain, without the risks of abuse, misuse and diversion seen with opioid an...
We have published hundreds of Neumentum news stories on BioPortfolio along with dozens of Neumentum Clinical Trials and PubMed Articles about Neumentum for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Neumentum Companies in our database. You can also find out about relevant Neumentum Drugs and Medications on this site too.